Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy

Figure 8

The correlation between SRSF9 expression and immune infiltrating cells in (a) KIRC, (b) LGG, (c) LIHC, (d) LUSC, (e) PCPG, (f) PRAD, (g) SKCM, (h) THCA, and (i) THYM using TIMER.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)